Eperisone Impurity 3 | CAS 191543-16-5 - Request Quote
Eperisone Impurity 3
| SZ CAT No: | SZ-E080005 |
| CAS No | 191543-16-5 |
| Mol.F. | C11H14O |
| Mol.Wt. | 162.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Eperisone Impurity 3 is chemically 1-(3-Ethylphenyl)propan-1-one. Eperisone Impurity 3 is supplied with detailed characterization data compliant with regulatory guideline. Eperisone Impurity 3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Eperisone.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 191543-16-5
Purchase 191543-16-5
Order 191543-16-5
Enquire 191543-16-5
price of 191543-16-5
191543-16-5 Supplier
191543-16-5 Manufacturer
191543-16-5 Exporter
buy high quality Eperisone Impurity 3
Purchase Eperisone Impurity 3
Eperisone Impurity 3 suppliers
Eperisone Impurity 3 manufacturers
Eperisone Impurity 3 price
Order Eperisone Impurity 3
Enquire Eperisone Impurity 3
Eperisone Impurity 3 cost
Eperisone Impurity 3 Supplier
Eperisone Impurity 3 Distributor
Eperisone Impurity 3 for Method Validation
Eperisone Reference Standard
Eperisone Impurity 3 for ANDA Filing
Eperisone Impurity 3 for Forced Degradation Studies
Eperisone Impurity 3 Identification Standards
Eperisone Impurity 3 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


